OTCQB: PHRRF | CSE: PHRM
HOME
COMPANY
PIPELINE
INVESTORS
NEWS
HOME
COMPANY
PIPELINE
INVESTORS
NEWS
We are
developing a patented,
long-acting ketamine (KET-100)
for neuropsychiatric disorders.
Corporate Presentation
November 2025
OTCQB: PHRRF | CSE: PHRM
Press Releases
View all press releases
Sign Up for Press Releases
*
Indicates required field
Email
*
SIGN UP
Contact Us
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario, M5C 1P1
Canada
Tel: 1-888-846-3171